Associate Professor St. John's University Jamaica, New York
According to the new legislation signed by the president in December 2022, Food and Drug Administration (FDA) do not require animal testing for human trial. The news resulted in several speculations and confusion in pharmaceutical scientists from academia and industry. It is a very perplexing issue for basic drug discovery researchers.
An engaging and enlightening symposium by the experts from the FDA and industry could be very helpful for several researchers. Purpose, goal, alternative strategies and most important what it real means for novel drug discovery in future. How will it impact academic research? Are the current alternatives of in vivo studies capable of correlating safety and efficacy in human? What is FDA 2.0 modernization act?
Learning Objectives:
FDA modernization act 2.0
3R of animal study vs 3As - Artificial tissues, Artificial Intelligence, Alternative Invertebrates
2D and 3D cell cultures assays, 3D tissues and Microfluidics based organ on chip